Imipra 25mg Tablet
By Imipra
Rx
10 Tablet in a Strip

Composition
Imipramine(25mg)

Manufacturer - Cyril Pharmaceuticals
F-68, Phase 7, Industrial Area, Mohali, Chandigarh.

Expires on or after
August, 2025

liver
Imipra 25mg Tablet should be used carefully in patients with liver disease. It may be necessary to adjust the dose of Imipra 25mg Tablet. Please consult your doctor for advice. It is recommended to have regular monitoring of liver function tests while taking this medicine. Dose adjustment may also be required in patients with liver impairment. If you have liver impairment or any concerns about it, please consult your doctor for proper guidance.

kidney
Imipra 25mg Tablet should be used carefully in patients with kidney disease. Dose adjustment might be necessary, so consult your doctor if you have kidney issues or concerns.

alcohol
It is advised to avoid drinking alcohol while taking Imipra 25mg Tablet, as it can lead to excessive drowsiness. This combination may cause increased drowsiness.

driving
Imipra 25mg Tablet can lead to side effects like drowsiness, blurred vision, and impaired alertness, affecting driving ability. Avoid driving or operating machinery if experiencing these symptoms.

pregnancy
Imipra 25mg Tablet may not be safe during pregnancy. Limited human studies show potential harm to the developing baby. Your doctor will assess risks and benefits. Please consult your doctor before use. It belongs to pregnancy category C; consult your doctor for guidance.

breastfeeding
Imipra 25mg Tablet is not recommended for use during breastfeeding as it may pass into breastmilk and harm the baby. Consult your doctor before taking Imipra 25mg Tablet to determine if it is safe for breastfeeding mothers.
Habit Forming | No |
Chemical Class | Dibenzazepines Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Tricyclic antidepressants |
₹5.9
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024